Market growth is driven by the rising prevalence of cancer, increasing cancer research, rising investments in regenerative medicine research, rising demand for monoclonal antibodies, and rapid growth in the biotechnology and biopharmaceutical industries.
What the Market Looks Like?
The global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%. North America is the largest regional market for primary cells.
Cancer, which has become the leading cause of death globally, accounted for 9.6 million deaths in 2018. The growth in the prevalence of this disease has resulted in a need to conduct extensive research for diagnosis and treatment; primary cells form an important part of this research.
Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960
What Drives the Market?
The growth of the Primary Cells Market is primarily influenced by the following factors:
- Increasing cancer research
- Advantages of primary human cells over cell lines
- Increasing demand for monoclonal antibodies
- Rapid growth in the biotechnology and biopharmaceutical industries
- Growing focus on personalized medicine
- Government investments for cell-based research
Primary cell culture contamination is one of the most common problems encountered in cell culture laboratories. The use of contaminated cells endangers cell physiology and often leads to incorrect results or causes the loss of unique cell lines. Contamination in cell cultures not only slows down cell metabolism but can also contaminate final products such as vaccines, which can destroy the entire batch.
Read more about Primary Cells Market@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960
